Latest News for: hemophilia
Edit
Hemophilia A Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, ...
GetNews 28 Aug 2025
Expression Therapeutics, LLC Hemophilia> A Key Companies Hemophilia A Key Products Hemophilia A- Unmet Needs Hemophilia A- Market Drivers and Barriers Hemophilia A- Future Perspectives and Conclusion ...
Edit
Acquired Hemophilia A Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA ...
GetNews 19 Aug 2025
Edit
East Bridgewater's Maddox Craven turns lemons into lemonade with hemophilia fundraiser
The Enterprise - Brockton 02 Aug 2025
Monday - Friday .
Edit
Hemophilia Pipeline Outlook Report 2025: Key 80+ Companies and Breakthrough Therapies Shaping the Future Landscape
GetNews 31 Jul 2025
Company Name Inactive Products Hemophilia> Key Companies Hemophilia Key Products Hemophilia- Unmet Needs Hemophilia- Market Drivers and Barriers Hemophilia- Future Perspectives and Conclusion Hemophilia Analyst Views Hemophilia Key Companies Appendix.
Edit
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors
PR Newswire 31 Jul 2025
"For people living with hemophilia, it is important to continually monitor and discuss bleed control with their healthcare professional," said Allison P ... a novel anti-TFPI therapeutic for hemophilia ... Hemophilia> ... World Federation of Hemophilia.
Edit
Be Bio Announces First Participant Dosed in BeCoMe-9 Trial of BE-101 in Hemophilia B
Business Wire 30 Jul 2025
Edit
Hemophilia A Pipeline Outlook Report 2025: Key 40+ Companies and Breakthrough Therapies Shaping the Future Landscape
GetNews 28 Jul 2025
Expression Therapeutics, LLC Hemophilia> A Key Companies Hemophilia A Key Products Hemophilia A- Unmet Needs Hemophilia A- Market Drivers and Barriers Hemophilia A- Future Perspectives and Conclusion ...
Edit
Marion Dugdale, a ‘True Academic Physician,’ Pioneered Hemophilia Care in Memphis (The University of Tennessee Health Science Center)
Public Technologies 18 Jul 2025
A leader in the diagnosis and treatment of hemophilia and other blood disorders, Dr ... Dugdale led the Hemophilia> Clinic at the University of Tennessee Health Science Center.
Edit
Hemophilia Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Centessa Pharmaceuticals, ...
GetNews 16 Jul 2025
Edit
Nashville area hemophilia patient receives groundbreaking gene therapy, hopes for a cure
Daily News Journal 30 Jun 2025
He was suddenly confronted with the the possibility of life-threatening internal bleeding due to his hemophilia ... Hailey has an even rarer type of the illness, an extreme form of hemophilia B ... What is hemophilia B and Hemgenix gene therapy?.
Edit
The Joplin Globe
26 Jun 2025
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
The Joplin Globe
26 Jun 2025
Edit
Henry Herald
23 Jun 2025
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia ...
Henry Herald
23 Jun 2025
New FRONTIER5 results show a direct switch to investigational ...
Edit
Phase I/II Study in Hemophilia A Suggests NXT007 May Have the Potential to Provide Hemostatic Normalization (Chugai Pharmaceutical Co Ltd)
Public Technologies 23 Jun 2025
Phase I/II Study in Hemophilia> A Suggests NXT007 May Have the Potential to Provide Hemostatic Normalization ... NXT007 is a Chugai originated project currently under development for hemophilia A ... emicizumab) which is widely used to treat hemophilia A.
Edit
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
PR Newswire 22 Jun 2025
"Continuous prophylactic coverage is critical to avoiding breakthrough bleeds in people living with hemophilia; with new non-factor therapeutic options, many people could have hesitations about switching treatment options ... Hemophilia>.
Edit
Hemophilia can’t stop Central NY baseball star from historic high school career: ‘He’s really overcome it’
The Post-Standard 19 Jun 2025
Updated. Jun. 19, 2025, 8.00 a.m. Phoenix baseball division 1 commit Ty Corey at Phoenix High School Tuesday, May 27, 2025, in Phoenix, N.Y. Scott Schild . [email protected] Scott Schild . [email protected]. By Kenny Lacy Jr. [email protected] ... ....
- 1
- 2
- Next page »